Verapamil and circadian variation of sudden cardiac death

American Heart Journal

Volumn 131, Issue 2, 1996, Pages 409-410

  Andersen, Lisbeth Tingsted ^a   Sigurd, Bjarne ^b   Hansen, Jørgen Fischer ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

^b NYKØBING FALSTER HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

VERAPAMIL;

ARTICLE; CIRCADIAN RHYTHM; HEART DEATH; HUMAN; INDUSTRIALIZATION; PRIORITY JOURNAL; SUDDEN DEATH; SYMPATHETIC TONE;

EID: 0030065116     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(96)90378-6     Document Type: Article

References (8)

1. Willich SN, Goldberg RJ, Maclure M, Perriello L, Muller JE. Increased onset of sudden cardiac death in the first three hours after awakening. Am J Cardiol 1992;70:65-8.
2. Muller JE, Ludmer PL, Willich SN, Tofler GH, Aylmer GM, Klangos I, Stone PH. Circadian variation in the frequency of sudden death. Circulation 1987;75:131-8.
3. Aronow WS, Ahn C. Circadian variation of primary cardiac arrest or sudden cardiac death in patients aged 62 to 100 years (mean 82). Am J Cardiol 1993;71:1455-6.
4. Peters RW, Muller JE, Goldstein S, Byington R, Friedman LM, for the BHAT Study group. Propanolol and the morning increase in the frequency of sudden cardiac death (BHAT Study). Am J Cardiol 1989;63;1518-20.
5. Beta-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with AMI. JAMA 1982;12:1707-14.
6. Aronow WS, Ahn C, Mercando AD, Epstein S, Kronzon I. Decrease in mortality by propranolol in patients with heart disease and complex ventricular arrhythymias is more an anti-ischemic than an antiarrhythmic effect. Am J Cardiol 1994;74:613-5.
7. Fischer Hansen J, Danish study group on verapamil in myocardial infarction. Review of postinfarct treatment with verapamil: combined experience of early and late intervention studies with verapamil in patients with acute myocardial infarction. Cardiovasc Drugs Ther 1994;8:543-7.
8. Vaage-Nilsen M, Rasmussen V, Holländer NH, Fischer Hansen J. The Danish study group on verapamil in myocardial infarction. Prevalence of transient myocardial ischaemia during the first year after myocaridal infarction. Effect of treatment with verapamil. Eur Heart J 1992;13:666-70.